An investigation published by The BMJ today raises fundamental questions about the transparency of information surrounding the safety of GlaxoSmithKline’s Pandemrix vaccine used in 2009-2010. Eight years after the 2009 H1N1 “swine flu” outbreak, new information is emerging of a striking difference in the number and frequency of adverse events reported for three GSK pandemic